A Proactive Outreach Intervention That Decreases Readmission After Hepatectomy
Overview
Authors
Affiliations
Background: After hepatectomy, 7%-19% of patients are readmitted within 30 days, accounting for substantial cost and poor patient experience. The purpose of this study was to analyze the impact of a proactive outreach intervention on readmissions.
Methods: Consecutive patients undergoing hepatectomy by a single surgeon 2012-2016 were identified in a prospectively maintained database. In August 2013 a postoperative intervention was implemented; an advanced practice provider called each patient within 72 hours of discharge. Readmission rates were compared pre- and postintervention using standard statistics.
Results: Two hundred thirty-one patients met the inclusion criteria and major hepatectomy was performed in 45.5% of patients. Although the complication rate was similar (25.0% preintervention and 19.4% postintervention, P = .324), readmissions within 30 days of operation decreased from 14.5% pre- to 6.5% postintervention (P = .046). Approximately 30% of outreach interactions required outpatient intervention. Factors associated with readmission on univariate analysis included increased operative time (P = .007), major hepatectomy (P = .012), hemi or extended hepatectomy (P = .032), second stage operation (P = .031), bile leak (P = 0.022), and any complication/modified Accordion complication ≥ 3 within 30 days (P <.0001). On multivariate analysis, lack of post-discharge intervention (P = .012) and bile leak (P = .031) were independently associated with readmission.
Conclusion: These data demonstrate the efficacy of a proactive communication intervention after discharge to decrease readmissions after hepatectomy. The additional work created by the intervention is likely offset by decreased inpatient care needs and costs. Identification of high-risk populations and application of technology are likely to lead to further improvements.
Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management.
MKoma A Med Res Arch. 2023; 11(1).
PMID: 37089816 PMC: 10118064. DOI: 10.18103/mra.v11i1.3135.
Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.
MKoma A Medicina (Kaunas). 2022; 58(5).
PMID: 35629984 PMC: 9144337. DOI: 10.3390/medicina58050567.
Kang E, Shin J, Griesemer A, Lobritto S, Goldner D, Vittorio J J Gastrointest Surg. 2021; 25(11):2851-2858.
PMID: 33825121 DOI: 10.1007/s11605-021-04995-2.
Enhanced recovery in liver surgery decreases postoperative outpatient use of opioids.
Lillemoe H, Marcus R, Day R, Kim B, Narula N, Davis C Surgery. 2019; 166(1):22-27.
PMID: 31103198 PMC: 6579699. DOI: 10.1016/j.surg.2019.02.008.
de Klein G, Brohet R, Liem M, Klaase J World J Surg. 2019; 43(7):1802-1808.
PMID: 30843099 DOI: 10.1007/s00268-019-04970-8.